Readers deserve to know not only what a study found, but how much confidence that finding can reasonably carry. Our evidence labels are editorial judgments anchored to study design, replication, relevance and the totality of available research.

Three visible labels

High evidence generally requires convergent, replicated human evidence or an authoritative regulatory record. Moderate evidence describes credible but limited human research, mixed results or important constraints. Preliminary evidence covers early human work, observational signals, animal research and mechanistic studies.

A label is not a permanent grade. We update it when stronger studies, safety signals, retractions or regulatory actions change the record.

How the judgment is made

The editorial desk begins with the claim the headline and article actually make. It then examines whether the source design can support that claim, whether the endpoint is clinically meaningful, how participants or models were selected, whether a suitable comparator was used, and how uncertainty was reported. Sample size, duration, missing data, conflicts and consistency with other evidence can move confidence up or down.

AI may organize a source packet and suggest a provisional grade, but it does not approve its own assessment. The responsible editor controls publication. Safety, efficacy, dosing and treatment language require human evidence review, and a story is held when the available review cannot support the proposed wording.

What a grade does not mean

The label is not a score for a journal, author, company or entire therapy. An authoritative regulator can provide high-confidence evidence that an action occurred while the underlying treatment question remains uncertain. Likewise, a technically strong animal experiment can receive a preliminary clinical grade because it cannot establish human benefit.

Grades are deliberately claim-specific. If later replication strengthens the conclusion, the article can be updated. If a retraction, safety signal or better-controlled study weakens it, the grade can fall. The revision record exists so readers can see that evidence assessment is an accountable editorial process rather than permanent branding.

THE BOTTOM LINE

Every consequential claim should reveal the strength and limits of the evidence beneath it.

Primary sourceVitalspan Wire editorial methodology ↗

Sources are selected for relevance and authority. Our newsroom distinguishes source statements from our analysis.

AI-assisted reporting disclosure

AI was used to organize source material and prepare reporting copy. Vitalspan Wire is accountable for the published text. Our standards prohibit invented quotations, sources, credentials, data and firsthand observations.

Medical note

This article provides general information, not diagnosis or treatment advice. Decisions about peptides, compounded drugs or other therapies belong with a qualified clinician who knows your history.